Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-134 Cr₹-141 Cr₹-146 Cr₹-134 Cr₹-113 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-134 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-134 Cr
Mar2025₹-141 Cr
Mar2024₹-146 Cr
Mar2023₹-134 Cr
Mar2022₹-113 Cr

How is Deferred Tax Assets / Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-134 Cr
Negative
Mar2025 ₹-141 Cr
Negative
Mar2024 ₹-146 Cr
Negative
Mar2023 ₹-134 Cr
Negative
Mar2022 ₹-113 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,874.1 Cr -2.3% 5% 7.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,944.0 Cr -2% 6% 9.6% Stock Analytics
DIVIS LABORATORIES ₹294,962.0 Cr -4% 22.9% 75.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,391.0 Cr -1.8% 1.8% 21.9% Stock Analytics
DR REDDYS LABORATORIES ₹115,267.0 Cr -0.4% 13.1% 13.7% Stock Analytics
CIPLA ₹112,620.0 Cr -0.9% 4.5% -8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-2.3%

5%

7.8%

SENSEX

1.4%

12.8%

-1.7%


You may also like the below Video Courses